Disseminated tuberculosis and diagnosis delay during the COVID-19 era in a Western European country: a case series analysis

Abstract

BackgroundDisseminated tuberculosis is frequently associated with delayed diagnosis and a poorer prognosis.ObjectivesTo describe case series of disseminated TB and diagnosis delay in a low TB burden country during the COVID-19 period.MethodologyWe consecutively included all patients with of disseminated TB reported from 2019 to 2021 in the reference hospital of the Northern Crown of the Metropolitan Area of Barcelona. We collected socio-demographic information, clinical, laboratory and radiological findings.ResultsWe included all 30 patients reported during the study period—5, 9, and 16 in 2019, 2020, and 2021 respectively—20 (66.7%) of whom were male and whose mean age was 41 years. Twenty-five (83.3%) were of non-EU origin. The most frequent system involvement was central nervous system (N = 8; 26.7%) followed by visceral (N = 7; 23.3%), gastro-intestinal (N = 6, 20.0%), musculoskeletal (N = 5; 16.7%), and pulmonary (N = 4; 13.3%). Hypoalbuminemia and anemia were highly prevalent (72 and 77%). The median of diagnostic delay was 6.5 months (IQR 1.8–30), which was higher among women (36.0 vs. 3.5 months; p = 0.002). Central nervous system involvement and pulmonary involvement were associated with diagnostic delay among women. We recorded 24 cured patients, two deaths, three patients with post-treatment sequelae, and one lost-to-follow up. We observed a clustering effect of patients in low-income neighborhoods (p < 0.001).ConclusionThere was a substantial delay in the diagnosis of disseminated TB in our study region, which might impacted the prognosis with women affected more negatively. Our results suggest that an increase in the occurrence of disseminated TB set in motion by diagnosis delay may have been a secondary effect of the COVID-19 pandemic.

Augmenting Radiological Diagnostics with AI for Tuberculosis and COVID-19 Disease Detection: Deep Learning Detection of Chest Radiographs

“…Timely detection of these illnesses is crucial for treatment and to stop them from spreading further. Early identification, proactive care, and regular monitoring are not just important [5] but are key to achieving the best possible outcomes in treatment and preventing complications linked with both COVID-19 and tuberculosis [6]. The integration of intelligence (AI) in recent times has significantly advanced the healthcare field, mainly because of the increased access to medical data [7].…”

Successful Management, in a Low-Resource Setting, of Disseminated Tuberculosis in a 3-Year Old Boy: A Case Report

“…Disseminated or miliary tuberculosis is defined as the presence of at least two non-contiguous sites resulting from lymphohematogenous dissemination of Mycobacterium tuberculosis , occurring as a result of progressive primary infection, reactivation and spread of a latent focus or due to iatrogenic origin [ 3 ]. Disseminated TB represents a life-threatening condition, especially in at-risk children and when diagnosis and treatment are delayed [ 4 , 5 , 6 ]. Clinical presentation of disseminated TB is nonspecific, it is commonly associated with fever of unknown origin and, depending on involved sites, with other generic symptoms attributable to other common diseases [ 7 ].…”